zanamavir

za·na·ma·vir

(zə-nä′mə-vîr′)
n.
A neuraminidase inhibitor used to treat influenza.
Mentioned in ?
References in periodicals archive ?
33) Oseltamivir and Zanamavir remain effective against most strains, but resistance is rising.
Among the 2009 influenza A (H1N1) viruses, the 87 tested for resistance to oseltamivir were 100% sensitive, and the 33 tested for resistance to zanamavir were 100% sensitive.
La infeccion por citomegalovirus se trata con ganciclovir; la debida al virus respiratorio sincitial, usualmente, con ribavirina; y la producida por el virus de la influenza, con zanamavir, oseltamavir, rimantadina y amantadina.
We are definitely going to produce, and are producing already, zanamavir as an alternative.
Two antiviral medications, oseltamivir and Zanamavir, would probably work to treat flu caused by the H5N1 virus, though studies still need to be done to prove that they would be effective.
Susceptibility testing continues for zanamavir (Relenza).
Treatment with rimantidine or zanamavir without vaccination had small savings (less than $5); treatment with oseltamivir without vaccination had a cost of 3 cents.
Two other antiviral medications, oseltamivir and zanamavir, would probably work to treat influenza caused by H5N1 virus, but additional studies are needed to demonstrate their current and ongoing effectiveness.
Testing for susceptibility of the H5N1 isolates to the neuraminidase inhibitor oseltamivir has demonstrated the sensitivity of these viruses to the drug; testing to determine susceptibility to the neuraminidase inhibitor zanamavir is under way.